In addition to baseline PSA levels, several novel reflex biomarkers have been validated to determine the risk of harboring aggressive PCa on biopsy31,32,33 in men with elevated serum PSA levels and/or abnormal digital rectal examinations and may help reduce the need for prostate biopsy. This evidence concerns the gene KLK3 and posterior cortical atrophy.